157 related articles for article (PubMed ID: 7615846)
1. Effects of treatment on the histopathology of leprosy.
Cree IA; Coghill G; Subedi AM; Abbot NC; Butlin SR; Samson PD; Beck JS
J Clin Pathol; 1995 Apr; 48(4):304-7. PubMed ID: 7615846
[TBL] [Abstract][Full Text] [Related]
2. Study of HLA-DR expression on skin lesions of leprosy before and during multiple drug therapy.
Abdel Latif AM; Essa EA
Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):104-10. PubMed ID: 12211894
[TBL] [Abstract][Full Text] [Related]
3. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.
Bahia El Idrissi N; Iyer AM; Ramaglia V; Rosa PS; Soares CT; Baas F; Das PK
PLoS One; 2017; 12(5):e0177815. PubMed ID: 28505186
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry in histoid leprosy.
Kontochristopoulos GJ; Aroni K; Panteleos DN; Tosca AD
Int J Dermatol; 1995 Nov; 34(11):777-81. PubMed ID: 8543410
[TBL] [Abstract][Full Text] [Related]
5. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
6. Persistence of lepromatous granuloma in clinically cured cases of leprosy.
Desikan P; Desikan KV
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):417-21. PubMed ID: 7594925
[TBL] [Abstract][Full Text] [Related]
7. Study of apoptosis in skin lesions of leprosy in relation to treatment and lepra reactions.
Ajith C; Gupta S; Radotra BD; Arora SK; Kumar B; Dogra S; Kaur I
Int J Lepr Other Mycobact Dis; 2005 Dec; 73(4):269-76. PubMed ID: 16830636
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.
Kamal R; Natrajan M; Katoch K; Arora M
Indian J Lepr; 2012; 84(4):287-306. PubMed ID: 23720894
[TBL] [Abstract][Full Text] [Related]
9. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
Emmanuel M; Gupte MD
Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
[TBL] [Abstract][Full Text] [Related]
10. A case report of erythroderma in a patient with borderline leprosy on reversal reaction: a result of the exacerbated reaction?
Miyashiro D; Vieira AP; Trindade MAB; Avancini J; Sanches JA; Benard G
BMC Dermatol; 2017 Dec; 17(1):16. PubMed ID: 29262820
[TBL] [Abstract][Full Text] [Related]
11. Neural pathology in leprosy during treatment and surveillance.
Porichha D; Mukherjee A; Ramu G
Lepr Rev; 2004 Sep; 75(3):233-41. PubMed ID: 15508900
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of relapse after multidrug therapy for leprosy in China.
Shen J; Yan L; Sun P
Lepr Rev; 2015 Jun; 86(2):165-9. PubMed ID: 26502687
[TBL] [Abstract][Full Text] [Related]
13. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
Singal A; Sonthalia S; Pandhi D
Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
[TBL] [Abstract][Full Text] [Related]
14. Methods for the classification of leprosy for treatment purposes.
Pardillo FE; Fajardo TT; Abalos RM; Scollard D; Gelber RH
Clin Infect Dis; 2007 Apr; 44(8):1096-9. PubMed ID: 17366457
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire.
Mempel M; Flageul B; Suarez F; Ronet C; Dubertret L; Kourilsky P; Gachelin G; Musette P
Am J Pathol; 2000 Aug; 157(2):509-23. PubMed ID: 10934154
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
Tejasvi T; Khaitan BK; Khanna N; Pandhi RK; Singh MK
Indian J Lepr; 2006; 78(4):329-37. PubMed ID: 17402345
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
Collings LA; Tidman N; Poulter LW
Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
[TBL] [Abstract][Full Text] [Related]
18. Short-course multi-drug therapy for leprosy patients.
Puavilai S; Timpatanapong P
J Med Assoc Thai; 1989 Jan; 72(1):33-6. PubMed ID: 2656897
[TBL] [Abstract][Full Text] [Related]
19. A comparative trial of single-dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
Desikan KV
Indian J Lepr; 2001; 73(4):364-6; author reply 366-7. PubMed ID: 11898472
[No Abstract] [Full Text] [Related]
20. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
